Tag: Omicron variant

Covid 19

Current awareness updates

COVID-19 lockdowns and school closures: what’s the impact on youth mental health?
The Mental Elf; 2021.
[Douglas Badenoch appraises a recent cross-sectional survey study, which looks at COVID-19 partial school closures and mental health problems.]

Investigation of SARS-CoV-2 variants of concern: variant risk assessments.
UK Health Security Agency (UKHSA); 2021.
[Risk assessment dated 09 December for Omicron variant added.]

Consensus statements on COVID-19.
UK Health Security Agency (UKHSA); 2021.
[Updated 10 December 2021: UKHSA has added the EMRG’s consensus statement for 24 November 2021 to its website.]

Resilience and recovery following COVID-19.
McIntosh B. British Journal of Healthcare Management 2021;27(11):263-264.
[The healthcare sector has a crucial role to play in the wider economic and social recovery of society following COVID-19. Events since March 2020 have highlighted the need to see health and public services as a crucial investment, not an afterthought.]

An evaluation of a virtual COVID-19 ward to accelerate the supported discharge of patients from an acute hospital setting.
Swift J. British Journal of Healthcare Management 2021;27(12):1-9.
[The virtual ward appeared to assist with earlier discharges, had a low rate of clinically necessary re-admissions, and seemed to reduce costs without compromising patient safety. The authors believe that this intervention could be applied across other NHS trusts facing similar capacity issues as a result of COVID-19.]

Nudging healthcare professionals to improve treatment of COVID-19: a narrative review.[Abstract]
Vilhelmsson A. BMJ Open Quality 2021;10(4):doi: 10.1136/bmjoq-2021-001522.
[Conclusion: Evidence suggests that different nudging techniques can be used in clinical settings as simple, cost-effective strategies to fight COVID-19, reduce complications for intubated patients, improve hand hygiene, increase vaccination rates and avoid unnecessary antibiotic prescriptions. These strategies could be important in the continued handling of the pandemic, which will not be over until the whole world reaches herd immunity from vaccination…]

COVID-19 rapid guideline: managing COVID-19 NICE guideline.
National Institute for Health and Care Excellence (NICE); 2021.
[This guideline covers the management of COVID-19 for children, young people and adults in all care settings. In December, NICE added new recommendations on COVID-19-associated pulmonary aspergillosis. NICE revised their statement about the Omicron variant in the recommendation on casirivimab and imdevimab.]

COVID-19 vaccination: resources for schools and parents.
UK Health Security Agency (UKHSA); 2021.
[17 December 2021: Added version 3 of the guidance for schools and guidance for parents.]

COVID-19: guidance for first responders.
UK Health Security Agency (UKHSA); 2021.
[Updated advice for first responders (as defined by the Civil Contingencies Act) and others where close contact may be required as part of their normal duties.]

COVID-19: infection prevention and control (IPC).
UK Health Security Agency (UKHSA); 2021.
[17 December 2021: Added UK IPC Cell consensus statement in response to the emergence of the Omicron variant of SARS-CoV-2. Added paragraph to main IPC guidance on risk assessment and use of RPE in response to Omicron variant.]

Covid 19

Current awareness updates

COVID-19: infection prevention and control (IPC).
UK Health Security Agency (UKHSA); 2021.
[November 2021 Updates: 1) Guidance broadened to include seasonal respiratory infections; 3 COVID-19 specific pathways removed; section on the hierarchy of controls added; physical distancing advice updated. 2) Updated to clarify text on aerosol generating procedures. 3) Dental appendix broadened to include seasonal respiratory infections; 3 COVID-19 specific pathways removed and replaced with respiratory and non-respiratory pathways.]

COVID-19 rapid guideline: managing COVID-19
National Institute for Health and Care Excellence (NICE); 2021.
[In November, NICE added a new recommendation on ivermectin.]

Daily Insight: Another test for NHS staff.
HSJ: Health Service Journal (Daily Insight) 2021;:7031436.
[A letter sent by Chris Whitty, Ruth May and Susan Hopkins has strengthened expectations on NHS staff who have just returned from abroad. NHS workers returning from any non red-list country must have a negative PCR test before returning to work. Also: New guidance has recommended that trusts relax the segregation of patients according to covid-19 risk. There is likely to be a developing picture on infection control guidance over the next few weeks in light of the Omicron variant. 30 November.]

Frequently asked questions: Demonstrating Covid-19 and vaccination status.
House of Commons Library; 2021.
[This briefing paper provides answers to frequently asked questions about demonstrating Covid-19 status (otherwise called Covid-19 status certification) and use of the NHS Covid Pass in England.]

Covid-19 status certification.
House of Commons Library; 2021.
[Covid-19 status certification (also referred to as a “vaccine passport”) has been proposed as a means of reducing the risk of transmitting the Covid-19 virus in a number of settings. This briefing explores the Government’s policy on certification. It also provides discussion on the scientific evidence and other issues associated with the use of certification.]

Responding to violence against women and children during COVID-19: impact on service provision, strategies and actions in the WHO European Region (2021).
World Health Organization (WHO); 2021.
[A new report published by WHO/Europe shows that helplines providing support to women and children experiencing violence saw a spike in calls during the first 9 months of the COVID-19 pandemic. The data in the new report was collected between January and September 2020, a time in which millions of people in the WHO European Region were confined to their homes because of lockdowns or other restrictive measures.]

UK vaccine response to the Omicron variant: JCVI advice.
Department of Health and Social Care (DHSC); 2021.
[Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant. This statement sets out the JCVI’s advice on extending the UK COVID-19 vaccination programme to offer booster doses to adults aged 18 to 39 years, and second doses to children and young people aged 12 to 15 years.]